Skip to content

Sourcing and supply continuity

Review packaging, storage and stability evidence for magnesium glycinate

Connect supplier storage instructions and retest dates to the actual package, handling conditions and finished-product stability program.

By MagneINNOUpdated 3 min read

The practical answer

Use storage instructions and retest or shelf-life statements supported for the specific material and package. Review unopened storage, opened-container handling and finished-product stability as separate situations. A supplier’s ingredient date does not automatically establish the shelf life of your finished formulation.

Ask what the date actually represents

A certificate may show a manufacturing date, retest date or expiration date. Ask the supplier to define the term and the conditions under which it applies. Do not treat retesting as an automatic extension or assume that every date describes an identical decision. The responsible quality team must determine what evidence is needed for continued use.

FDA’s dietary-supplement CGMP guidance discusses holding conditions and explains that a stated shelf life or expiration date should have supporting data. [1] That principle does not create a universal storage temperature, humidity limit or duration for every magnesium glycinate ingredient.

Review the package as part of the evidence

Photograph and document damaged closures or compromised containers at receiving. Assess the affected material through the site’s quality process rather than relying only on an intact outer carton. A new liner, smaller repack or repeated opening can create a situation different from the supplier’s unopened-package study.

AreaQuestion for the supplier or quality team
Primary packageWhich liner, closure and contact materials were used in the supporting study?
Storage conditionsWhat conditions were evaluated and what monitoring is expected?
DistributionHow are damage or excursions assessed on receipt?
Opened containersWhat handling, resealing and use controls are appropriate?
Retest or expiryWhat attributes and decision rules support the stated date?
Change controlWhich package or storage changes require reassessment?

On smaller screens, scroll the table horizontally.

Select attributes that matter to the product

Water activity and total moisture are different properties. FDA’s technical discussion explains why available water is relevant to food stability. [2] A moisture result alone should not be used to infer every microbial or physical stability outcome, particularly after the ingredient becomes part of a gummy or liquid system.

  • Consider identity, assay and relevant contaminants alongside physical changes such as caking or altered flow.
  • Use the appropriate water or moisture measurement, and include water activity when relevant to the formulated product.
  • Define the intended package, observation schedule and acceptance criteria before beginning a study.
  • Record actual storage and transport conditions so unexpected results can be investigated.
  • Retain evidence linking each study sample to its ingredient lot, formulation and packaging configuration.

Keep ingredient and finished-product conclusions separate

An ingredient may remain within its specification while the finished product changes in taste, texture, distribution or assay. Conversely, a finished-product package may protect the formula differently from a bulk liner. Evaluate the finished formulation in the package actually intended for sale.

This checklist does not assign a shelf life, endorse a preservation method or authorize use of expired or damaged material. It helps a buyer request the records necessary for a justified decision. When the evidence does not cover the actual storage or handling situation, document the gap and ask the responsible quality team what further assessment is needed.

Sources & further reading

  1. FDA: Dietary supplement CGMP small entity compliance guide
  2. FDA: Water activity in foods
This guide supports ingredient qualification and formulation planning. It does not establish a clinical dose, certify a finished product, or replace current lot documentation. General references explain the underlying topic; they do not independently verify MagneINNO-specific performance claims.